Quinoclamine is a naphthoquinone derivative and is an NF-κB inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 89 | |
10 mg | In stock | $ 151 | |
20 mg | In stock | $ 270 | |
50 mg | In stock | $ 490 | |
100 mg | In stock | $ 784 |
Description | Quinoclamine is a naphthoquinone derivative and is an NF-κB inhibitor. |
In vitro | Quinoclamine induces the differentiation of U-937 cells into macrophage-like cells. Quinoclamine inhibits NF-κB activities in HepG2 cells (IC50: 1.7 μM). Quinoclamine inhibits induced NF-κB activities in lung and breast cancer cell lines. Quinoclamine affects the expression levels of genes involved in cell cycle or apoptosis. Quinoclamine down-regulates the expressions of UDP glucuronosyltransferase genes involved in phase II drug metabolism. Quinoclamine (1-4 μM; 30 minutes ) inhibits endogenous NF-κB activity in HepG2 cells through the inhibition of IκB-α phosphorylation and p65 translocation . |
CAS No. | 2797-51-5 |
Chemical Formula | C10H6ClNO2 |
Molecular Weight | 207.61 |
Solubility | DMSO: 250 mg/mL (1204.18 mM), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom